Cresco Labs (CRLBF) Return on Capital Employed Growth (1y) (2022 - 2026)
Cresco Labs (CRLBF) Return on Capital Employed Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.82 Bn | 32.08 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.67 Bn | 30.73 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.70 Bn | 23.64 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.15 Bn | 21.00 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.16 Bn | 18.35 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.86 Bn | 16.55 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.67 Bn | 12.24 Bn | 785.00 Mn | 1,195.00 |
| 10 | Cresco Labs | 244.03 Mn | 180.46 Mn | 75.45 Mn | -1,012.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,012.00 |
| Dec 31, 2025 | -1,087.00 |
| Sep 30, 2025 | -398.00 |
| Jun 30, 2025 | 758.00 |
| Mar 31, 2025 | 1,277.00 |
| Dec 31, 2024 | 1,587.00 |
| Sep 30, 2024 | 3,112.00 |
| Jun 30, 2024 | 883.00 |
| Mar 31, 2024 | 239.00 |
| Dec 31, 2023 | -149.00 |
| Sep 30, 2023 | -2,676.00 |
| Jun 30, 2023 | -41.00 |
| Mar 31, 2023 | 316.00 |
| Dec 31, 2022 | 580.00 |
| Mar 31, 2022 | -1,293.00 |